Markets
← Back to Stocks
VTRS
VIATRIS INC
Health Care · Pharmaceuticals
$13.51
-1.75%
Vol: 3.1M
Araverus Market Read
Thursday, March 19, 2026
Viatris hosts investor event March 19 after recent dividend payment, signaling engagement with shareholders amid portfolio rationalization.
VTRS hosting investor event in New York City on March 19, 2026. Company paid quarterly dividend of $0.12/share on March 18 (2026 policy: $0.48/share annually). FDA accepted supplemental NDA for MR-141 (phentolamine ophthalmic solution 0.75%) for presbyopia. Current price around $13.80 reflects pipeline progress.
Price 50d 200d
Previous Market Reads
2 of 2 daysSector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$15.5B
P/E (TTM)—
Forward P/E5.1
Beta0.80
Div Yield350.00%
Prev Close$13.75
RSI (14-Day)
33Neutral
0305070100
52-Week Range
$6.85$13.51$16.47
From High-18.0%
From Low+97.2%
Moving Averages
50d SMA
$14.11-4.3%
200d SMA
$10.96+23.2%
Price between 50d and 200d. Testing 50d support.
Returns
1W
-2.1%
1M
-15.1%
3M
+18.9%
6M
+43.2%
1Y
+48.5%
YTD
+9.3%
Volume
Today3.1M
20d Avg12.1M
Ratio0.26x